Do you have to take Mounjaro forever?

What happens to your weight when you stop taking Mounjaro?

This is a question our prescribers hear most weeks, and the honest answer is that stopping usually brings weight back. Tirzepatide works by activating the GIP and GLP-1 receptors that influence appetite, gastric emptying and how full you feel. Once you stop, those signals return to their pre-treatment state. Your appetite comes back. The extra fullness disappears. The body, quite predictably, moves back toward the weight it was defending before treatment started.

Trial data from the SURMOUNT programme, published in the New England Journal of Medicine, showed participants losing around 20–21% of body weight at the highest dose over 72 weeks. Follow-up data from semaglutide trials found that roughly two-thirds of lost weight returned within a year of stopping, and tirzepatide evidence points in the same direction. This does not mean treatment has failed. It means obesity has a biological basis that tirzepatide manages rather than cures. Framing it the same way you might frame a cholesterol medicine or an antihypertensive is often more useful than thinking of it as a finite course.

Whether that biology applies to you specifically, and whether continued treatment is clinically appropriate, is a conversation for your prescriber. You can read more about whether staying on Mounjaro long-term is safe or explore the full Mounjaro treatment overview for broader context.

Does the UK licence or NICE guidance set a time limit on Mounjaro?

Not in the same way as Wegovy. NICE's appraisal of semaglutide (TA875) recommended it only within specialist weight management services and for a maximum of two years. NICE's appraisal of tirzepatide (TA1026, updated September 2025) does not set a fixed duration cap. It does say that if a person loses less than 5% of their body weight after six months at the highest tolerated dose, continuing should be reviewed. Beyond that, duration is a clinical call made between prescriber and patient.

The UK licence for Mounjaro in weight management (BMI 30 or above, or 27 or above with at least one weight-related condition) is similarly silent on a maximum treatment period. What matters is ongoing clinical review. At nume, no repeat order goes out without a prescriber looking at it again, that re-review includes progress, tolerability and whether continuing is still the right choice. It is not automatic.

It is worth knowing that the cost picture can shift over time too. The Eli Lilly price increase that took effect in September 2025 changed the private-market landscape noticeably, and that context matters for anyone planning a longer treatment course.

Can you take breaks from Mounjaro, or stop and restart?

Pausing is possible, but it is not without practical consequences. Side effects, particularly nausea and digestive discomfort, often revisit when treatment restarts because your system loses the tolerance it built up during the original titration. Depending on how long the break was, a prescriber may want to start again at a lower dose rather than pick up where you left off.

Weight regain during a break is also common, and can be demoralising. Whether a planned pause makes sense (for surgery, for pregnancy planning, or for cost reasons) is worth discussing in advance rather than just stopping. The NHS tirzepatide medicines page advises patients not to stop treatment without speaking to their healthcare provider first, and that is sound advice for restarts too.

If you are wondering about specific circumstances that might affect your treatment, such as a pre-existing gastrointestinal condition or age-related eligibility questions, those details are covered separately. The short answer is always the same: talk to your prescriber before making any change.

So do you have to use Mounjaro forever? A practical frame

Nobody has to do anything forever. The more useful question is: what are you trying to achieve, and is the benefit of continuing treatment greater than the cost and the inconvenience? For many people, the biology of weight regulation means that stopping reliably triggers regain. For others, lifestyle changes during treatment are substantial enough that some weight is maintained after stopping, though rarely all of it.

There is no shame in needing a medicine long-term. The framing that weight loss should be achievable through willpower alone, and that a medicine is only a temporary prop, does not reflect what the clinical evidence shows. Equally, some people do stop after reaching their goal and manage well. Your prescriber's job is to help you figure out which situation you are in, and to review that regularly.

If you want to explore what treatment looks like in practice, including the clinical assessment that precedes any prescription, the weight-loss treatments page sets out how the process works at nume. The wider landscape of weight-loss options is also worth understanding before committing to any one path. You can also read about what long-term use of tirzepatide looks like in practice.

If you have specific questions about your own situation, our team is available seven days a week. A free consultation is the straightforward first step.